• About us
• Contact

Advertisement

Person › Details

Aymeric le Chatelier (Ipsen S.A. (Euronext: IPN; ADR: IPSEY))

le Chatelier, Aymeric (Ipsen 201603 CFO)

 

	Organisation	Ipsen S.A. (Euronext: IPN; ADR: IPSEY)
	Group	Ipsen (Group)
	Product	pharmaceutical
	Product 2	Dysport®

Record changed: 2020-01-27

Advertisement

More documents for Aymeric le Chatelier

• [1] Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.